Home
Live Updates
Capsida Biotherapeutics to Present New Preclinical Data on Potential of Systemically Delivered Next-Generation AAV Therapeutics for Treatment of Genetic Epilepsy : comparemela.com
Capsida Biotherapeutics to Present New Preclinical Data on Potential of Systemically Delivered Next-Generation AAV Therapeutics for Treatment of Genetic Epilepsy
/PRNewswire/ -- Capsida Biotherapeutics ("Capsida") today announced it will present new preclinical data showing the potential for its engineered...
Related Keywords
,
Nicholas Flytzanis ,
Susan Catalano ,
Prnewswire Capsida Biotherapeutics ,
Peter Anastasiou ,
Mingshan Xue ,
Epilepsy Therapies Diagnostics Development Symposium ,
Baylor College Of Medicine ,
Epilepsy Therapies ,
Diagnostics Development Symposium ,
Baylor College ,
Genetic Epilepsy Caused ,
Genetic Epilepsy ,
Capsida Biotherapeutics ,
Health Care Amp Hospitals ,
Biotechnology ,
Medical Pharmaceuticals ,
Clinical Trials Amp Medical Discoveries ,
comparemela.com © 2020. All Rights Reserved.